急性地高辛中毒的生理药代动力学建模及地高辛特异性抗体片段的影响
本文构建并验证了地高辛的生理药代动力学(PBPK)模型,通过与6例急性地高辛中毒患者观察数据比较来评估其在急性中毒管理中的模拟能力,并与标准二室PK模型模拟对比。PBPK模拟与吸收后血浆地高辛浓度吻合良好,预测准确度在实测临床值的1.5倍以内,而同一批患者的二室模拟产生最大4.9倍偏差。作者认为PBPK建模在生成急性地高辛中毒及地高辛-Fab反应的逼真模拟方面优于传统二室建模,其连续模拟能力有潜力为替代性、更廉价且更安全的地高辛-Fab给药策略提供依据。
要点
- PBPK模型模拟与6例急性地高辛中毒患者吸收后血浆浓度吻合良好,预测准确度在实测值的1.5倍以内。
- 同一批患者中二室PK模型模拟产生最大4.9倍偏差,PBPK模型更准确。
- 作者认为PBPK建模在生成急性地高辛中毒及地高辛-Fab反应的逼真模拟方面优于传统二室建模。
- 作者认为PBPK的模拟能力有潜力为替代性、更廉价且更安全的地高辛-Fab给药策略提供依据。
- 原文指出推荐的地高辛-Fab剂量在药代动力学上缺乏依据且理论上过量。
适用人群与场景
- 6例急性地高辛中毒患者,用于比较PBPK模拟与观察到的吸收后血浆地高辛浓度。
研究设计与关键结果
- 研究类型为PBPK建模与验证研究,构建地高辛PBPK模型并与6例急性中毒患者的观察数据比较,同时与标准二室PK模型模拟对比。
- PBPK模型模拟与6例急性地高辛中毒患者吸收后血浆地高辛浓度吻合良好,预测准确度在实测临床值的1.5倍以内。
- 同一批患者的二室PK模型模拟产生最大4.9倍偏差,PBPK模型更准确。
- 原文指出推荐的地高辛-Fab剂量在药代动力学上缺乏依据且理论上过量。
- 作者认为PBPK建模在生成急性地高辛中毒及地高辛-Fab反应的逼真模拟方面优于传统二室建模。
- 作者认为PBPK的模拟能力有潜力为替代性、更廉价且更安全的地高辛-Fab给药策略提供依据。
证据类型、等级与局限
- 证据类型:PBPK建模与验证研究(模型构建与临床观察数据比较)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为PBPK建模有潜力为急性地高辛中毒的替代性、更廉价且更安全的地高辛-Fab给药策略提供依据。
- 原文指出推荐的地高辛-Fab剂量在药代动力学上缺乏依据且理论上过量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: Recommended doses of digoxin-specific antibody fragments (digoxin-Fab) for treatment of acute digoxin poisoning are pharmacokinetically unsubstantiated and theoretically excessive. Physiologically based pharmacokinetic (PBPK) modelling creates clinical simulations which are closely related to physiological and pharmacokinetic behaviour. This paper details the formulation of a PBPK model of digoxin and explores its use as a simulation tool for acute digoxin toxicity and its management.
MATERIALS AND METHODS: A PBPK model of digoxin was constructed and validated for acute digoxin poisoning management by comparing simulations with observed individual acute overdose patients. These simulations were compared with standard two-compartment PK model simulations.
RESULTS: PBPK model simulations showed good agreement with post-absorption plasma concentrations of digoxin measured in 6 acute overdose patients. PBPK predictions were accurate to 1.5-fold or less of observed clinical values, proving to be more accurate than two-compartment simulations of the same patients which produced up to a 4.9-fold change.
CONCLUSIONS: Compared to conventional two-compartment modelling, PBPK modelling is superior in generating realistic simulations of acute digoxin toxicity and the response to digoxin-Fab. Simulation capacity provides realistic, continuous data which has the potential to substantiate alternative, less expensive, and safer digoxin-Fab dosing strategies for the treatment of acute digoxin toxicity.
参考来源
- Bracken LM, Chan BSH, Buckley NA, et al. Physiologically based pharmacokinetic modelling of acute digoxin toxicity and the effect of digoxin-specific antibody fragments. Clin Toxicol (Phila). 2018. PMID: 30306803. doi:10.1080/15563650.2018.1503288
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。